Ontology highlight
ABSTRACT: Purpose: Alcohol-induced damage to bone microstructure leads to alcoholic osteopenia (AOP). While prior studies have demonstrated alcohol's negative impact on bone density, the mechanisms by which alcohol induces osteoporosis through immune pathways, gut microbiota dysbiosis, and metabolic alterations remain insufficiently characterized. Given that alcohol is primarily absorbed in the upper gastrointestinal tract, the research aims to elucidate the role of spatial distribution disorders in gut microbiota and metabolites in the pathogenesis of alcohol-induced osteoporosis and to evaluate the potential of microbiota supplementation and targeted immunosuppressants as therapeutic strategies for related bone diseases. Methods: Eight-week-old male C57BL/6 mice were used to establish an osteoporosis model via the force-feeding method. Bone loss was validated using micro-computed tomography (micro-CT). Segmented intestinal samples and fecal samples were analyzed by 16S rRNA sequencing and metabolomics. Mechanistic studies were conducted by supplementing R. intestinalis, prostaglandin D2 (PGD2), and its specific immune inhibitor, Ramatroban. Analytical methods included tartrate-resistant acid phosphatase (TRAP) staining, flow cytometry, and enzyme-linked immunosorbent assay (ELISA). For statistical analysis, paired t-tests were used for comparisons between two groups, while one-way analysis of variance (ANOVA) followed by Tukey's post hoc test was employed for multiple group comparisons. Results: Alcohol disrupts the spatial complexity of intestinal segments and fecal microbiota in mice, causing metabolic dysregulation and ultimately leading to elevated PGD2 levels. This, in turn, triggers Th17/Treg immune imbalance and osteoclast activation, resulting in bone loss. Supplementation with the probiotic R. intestinalis or inhibition of PGD2 can significantly improve bone density and alleviate inflammation. Conclusion: Due to the complex spatial distribution of gut microbiota, fecal or colonic microbiota alone cannot fully represent the entire gut environment. The microbiota and metabolites in the lower gastrointestinal tract are better indicators of the host's systemic metabolic status, while the sensitive changes in microbial diversity in the upper gastrointestinal tract also play a significant role in disease progression. This study demonstrates that alcohol-induced elevation of prostaglandin D2 (PGD2) is a key pathogenic factor in alcohol-induced osteoporosis (AOP). PGD2 accelerates bone loss by promoting osteoclast formation through the activation of Th17 cells. Furthermore, this study highlights the importance of investigating the spatial distribution of gut microbiota and metabolites, providing potential targets and novel strategies for the precise treatment of AOP and other diseases associated with external stimuli.
INSTRUMENT(S): Liquid Chromatography MS - negative - reverse phase, Liquid Chromatography MS - positive - reverse phase
PROVIDER: MTBLS11887 | MetaboLights | 2025-03-28
REPOSITORIES: MetaboLights
| Action | DRS | |||
|---|---|---|---|---|
| HFX10_1865701_CN_QC1.raw | Raw | |||
| HFX10_1865701_CN_QC2.raw | Raw | |||
| HFX10_1865701_CN_QC3.raw | Raw | |||
| HFX10_1865701_CN_QC4.raw | Raw | |||
| HFX10_1865701_CN_QC5.raw | Raw |
Items per page: 1 - 5 of 122 |